Authorities investigate counterfeit rabies vaccine batch KE25012 after it failed potency tests, raising public safety concerns.

Authorities investigate counterfeit rabies vaccine batch KE25012 after it failed potency tests, raising public safety concerns.

Investigation launched into counterfeit 'Abhayrab' rabies vaccine batch, raising concerns about patient safety and public health.

A seized batch of Abhayrab rabies vaccine from an unlicensed Delhi premises was found misbranded and substandard. The finding has triggered tighter nationwide surveillance and legal action against unauthorised drug networks.